Correlation Between PureTech Health and AIM ImmunoTech

Can any of the company-specific risk be diversified away by investing in both PureTech Health and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PureTech Health and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PureTech Health plc and AIM ImmunoTech, you can compare the effects of market volatilities on PureTech Health and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PureTech Health with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of PureTech Health and AIM ImmunoTech.

Diversification Opportunities for PureTech Health and AIM ImmunoTech

0.44

Correlation Coefficient

PureTech Health  AIM ImmunoTech

Very weak diversification

The 3 months correlation between PureTech and AIM is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding PureTech Health plc and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and PureTech Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PureTech Health plc are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of PureTech Health i.e., PureTech Health and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between PureTech Health and AIM ImmunoTech

Assuming the 90 days trading horizon PureTech Health plc is expected to generate 0.28 times more return on investment than AIM ImmunoTech. However, PureTech Health plc is 3.63 times less risky than AIM ImmunoTech. It trades about -0.11 of its potential returns per unit of risk. AIM ImmunoTech is currently generating about -0.08 per unit of risk. If you would invest  16,740  in PureTech Health plc on December 2, 2024 and sell it today you would lose (2,320) from holding PureTech Health plc or give up 13.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

PureTech Health plc  vs.  AIM ImmunoTech

PureTech Health plc

Risk-Adjusted Performance

Very Weak

Over the last 90 days PureTech Health plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AIM ImmunoTech

Risk-Adjusted Performance

Very Weak

Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with PureTech Health and AIM ImmunoTech

The main advantage of trading using opposite PureTech Health and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PureTech Health position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.

The idea behind PureTech Health plc and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.